JPRN-UMIN000006363已完成未知
Bladder preservation therapy with GC radiation against invasive bladder cancer. - Bladder preservation therapy with GC radiation against invasive bladder cancer.
Department of Urology, Yamaguchi University, School of Medicine0 个研究点目标入组 38 人开始时间: 2011年9月16日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 38
研究概览
简要总结
Chemoradiotherapy using gemcitabine and cisplatin for muscle-invasive bladder cancer is effective for local cancer control and shows no significant difference in oncological prognosis compared with radical cystectomy.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •1 Patients who have contraindication against gemcitabine and/or cisplatin. 2 Patients who received previous irradiation to pelvis. 3 Others, patients who have unsuitable condition.
研究者
相似试验
进行中(未招募)
2 期
Intravesical Gem/Doce in Patients With NMIBCUrinary Bladder CancerNCT05644041University of Arizona31
已完成
3 期
Radiation Therapy or Surgery in Treating Patients Receiving Chemotherapy for Bladder CancerBladder CancerNCT00867347Institute of Cancer Research, United Kingdom45
终止
2 期
Neoadjuvant Gemcitabine and Fractionated, Weekly Cisplatin For Muscle Invasive Bladder Cancer and Patients Not Candidates For High Dose CisplatinInvasive Bladder CancerBladder CancerNCT02030574Brown University2
尚未招募
2 期
Radiotherapy for BCG-unresponsive Non-muscle-invasive Carcinoma in Situ (CIS) Bladder CancerBladder CancerNCT06310369European Organisation for Research and Treatment of Cancer - EORTC50
Unknown
不适用
A Study Using MRI To Assess Bladder Motion During RadiotherapyBladder CancerNCT03409029The Christie NHS Foundation Trust20
